Document Detail

Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.
MedLine Citation:
PMID:  14597034     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To evaluate the safety and efficacy of photodynamic therapy (PDT) with verteporfin in the treatment of patients with choroidal neovascularization (CNV) secondary to central serous chorioretinopathy (CSC). DESIGN: Open-label, two-center, noncomparative, prospective interventional case series. METHODS: Consecutive patients with subfoveal or juxtafoveal CNV secondary to CSC were recruited and treated with a standard regimen of PDT with verteporfin. At regular 3-month follow-up examinations, re-treatment was considered if fluorescein angiography showed evidence of leakage. Outcome measures included the proportion of patients who had improvement (gained 2 more lines), stable, or loss (dropped in 2 or more lines) in vision at the final follow-up and the changes in best-corrected visual acuity (BCVA) from baseline. RESULTS: Ten eyes of 10 patients were recruited into the study. The mean age of the patients was 57.3 years with a mean follow-up duration of 12.6 months. At the last follow-up, six (60%) eyes gained 2 or more lines of BCVA with four (40%) patients having final BCVA of within 1 line. No patient lost 2 or more lines of BCVA. The mean logarithm of the minimal angle of resolution BCVA improvement after PDT was 2.4 lines (Wilcoxon signed-rank test, P =.013). No patient suffered serious ocular or systemic complications from PDT. CONCLUSIONS: Photodynamic therapy with verteporfin therapy is a safe and well-tolerated treatment in patients with CNV associated with CSC. A randomized, controlled trial with a longer follow-up period is warranted to further study the efficacy of PDT in the management of CNV secondary to CSC.
Wai Man Chan; Dennis S C Lam; Timothy Y Y Lai; Kenneth S C Yuen; David T L Liu; Carmen K M Chan; Wei Qi Chen
Related Documents :
10406604 - The treatment of traumatic optic neuropathy: the international optic nerve trauma study.
18628724 - Predictors of anti-vegf-associated retinal pigment epithelial tear using fa and oct ana...
23549424 - Endovascular repair versus open repair of ruptured abdominal aortic aneurysms: a multic...
10684834 - Prospective surveillance of sympathetic ophthalmia in the uk and republic of ireland.
9553664 - The role of pneumatic compression in the treatment of postmastectomy lymphedema. a rand...
24093314 - Endovascular aortic aneurysm repair in patients with hostile neck anatomy.
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of ophthalmology     Volume:  136     ISSN:  0002-9394     ISO Abbreviation:  Am. J. Ophthalmol.     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-11-04     Completed Date:  2003-11-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370500     Medline TA:  Am J Ophthalmol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  836-45     Citation Subset:  AIM; IM    
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Hong Kong, Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Choroidal Neovascularization / drug therapy*,  etiology
Fluorescein Angiography
Follow-Up Studies
Middle Aged
Photochemotherapy / methods*
Photosensitizing Agents / therapeutic use*
Porphyrins / therapeutic use*
Prospective Studies
Retinal Diseases / complications*
Treatment Outcome
Visual Acuity
Reg. No./Substance:
0/Photosensitizing Agents; 0/Porphyrins; 129497-78-5/verteporfin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Macular translocation surgery with 360-degree peripheral retinectomy following ocular photodynamic t...
Next Document:  Positron emission tomography scanning in essential blepharospasm.